Trabeculectomy in Eyes With High Myopia

Author:

Abe Ricardo Y.12,Oltramari Laura2,Vessani Roberto M.3,Schimiti Rui B.1,Magacho Leopoldo45,Kanadani Fábio N.6,Costa Vital P.1

Affiliation:

1. Department of Opthalmology, University of Campinas—UNICAMP

2. Hospital Oftalmológico de Brasília, Brasília, Distrito Federal

3. Department of Ophthalmology and Visual Science, Glaucoma Service, Federal University of Sao Paulo, São Paulo

4. Department of Ophthalmology, Federal University of Goiás

5. VER Hospital de Olhos, Goiânia, Goiás

6. Department of Ophthalmology, Glaucoma Institute of Belo Horizonte, Belo Horizonte, Brazil

Abstract

Précis: Primary trabeculectomy was safe and effective at lowering intraocular pressure (IOP) in patients with primary open angle glaucoma and high myopia. Purpose: To investigate the efficacy and safety of trabeculectomy in patients with glaucoma and high myopia. Patient and Methods: Retrospective case-control study. Glaucomatous patients with high myopia undergoing primary trabeculectomy surgery with at least 1 year of follow-up were compared with an age-matched control group without high myopia undergoing the same procedure. Surgical success was defined as: IOP ≤ 15 mm Hg with (qualified) or without (complete) antiglaucoma medications and at least 20% reduction from baseline IOP at the end of 48 months of follow-up. Results: We included a total of 90 eyes from 90 patients (45 eyes with high myopia and 45 controls). Within the 90 eyes, 70 eyes underwent trabeculectomy and 20 eyes underwent combined phacoemulsification and trabeculectomy. Although patients with high myopia had higher chances for failure (37% vs. 22%) compared with controls, the difference was not statistically significant (P=0.067). In the multivariable analysis, patients of African descent (P=0.043) and those with juvenile glaucoma (P=0.001) had more chances of failure, even after adjusting for myopia. There was no statistically significant difference between complication rates in both groups. Conclusion: Trabeculectomy was effective in reducing IOP in patients with high myopia and glaucoma, without the additional risk of complications compared with a control group.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3